Supriya Lifesci. vs Sun Pharma.Inds.
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Supriya Lifesci. currently has the stronger revenue growth signal.
Supriya Lifesci. show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Supriya Lifesci. | Sun Pharma.Inds. |
|---|---|---|
| Current Price | ₹931 | ₹1,801 |
| Market Cap | ₹7,929.17 Cr. | ₹4.44 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 39.9 | 35.18 |
| ROE (%) | 19.06 | 15.95 |
| Debt/Equity | — | 0.06 |
| Sales Growth 5Y (%) | 16.17 | 11.78 |
| Profit Growth 5Y (%) | 75.33 | 5.41 |
| Promoter Holding (%) | 68.3 | 54.48 |
| Revenue Rank | Rank 2 | Rank 3 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | No information |
| Fundraise | No information | No information |